To elucidate its underlying biomechanism, we performed a transcriptomic RNA sequencing (RNA-seq) to profile the signaling pathways and key genes affected by ICAM1-DXd treatment in PDX tumor tissues (Fig. 6a). This evidence concerns the gene ICAM1 and neoplasm.